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For the first time a microcystin-degrading bacterium (NV-3 isolate) has been isolated and characterized from a NZ lake.
Cyanobacterial blooms in New Zealand (NZ) waters contain microcystin (MC) hepatotoxins at concentrations which are a risk to
animal and human health. Degradation of MCs by naturally occurring bacteria is an attractive bioremediation option for removing
MCs from drinking and recreational water sources. The NV-3 isolate was identified by 16S rRNA sequence analysis and found
to have 100% nucleotide sequence homology with the Sphingomonas MC-degrading bacterial strain MD-1 from Japan. The NV-3
isolate (concentration of 1.0 × 108 CFU/mL) at 30∘C degraded a mixture of [Dha7]MC-LR and MC-LR (concentration 25𝜇g/mL)
at a maximum rate of 8.33 𝜇g/mL/day. The intermediate by-products of [Dha7]MC-LR degradation were detected and similar to
MC-LR degradation by-products. The presence of three genes (mlrA, mlrB, and mlrC), that encode three enzymes involved in
the degradation of MC-LR, were identified in the NV-3 isolate. This study confirmed that degradation of [Dha7]MC-LR by the
Sphingomonas isolate NV-3 occurred by a similar mechanism previously described for MC-LR by Sphingomonas strain MJ-PV
(ACM-3962). This has important implications for potential bioremediation of toxic blooms containing a variety of MCs in NZ
waters.
1. Introduction
Toxic cyanobacterial blooms in eutrophic lakes, ponds, and
reservoirs are a common occurrence around the world [1–3].
Cyanobacteria of the genera Microcystis, Anabaena, Nostoc,
and Planktothrix produces a wide range of potent toxins,
including a family of heptapeptide hepatotoxins, referred to
as microcystins (MCs). Microcystins are the most frequently
detected cyanobacterial toxins, which cause hepatotoxicity
and tumor promotion in wild animals, livestock, and humans
[2, 4, 5]. Epidemiological studies of primary liver cancer
in China and the death of 56 patients during a dialysis
treatment in Caruaru, Brazil triggered worldwide concern
about toxicity of MCs [4, 5]. Approximately 75 variants of
MCs have been identified andMC-L (leucine) R (arginine) is
the most common variant of MCworldwide [1, 6–9]. Limited
studies in New Zealand (NZ) have reported the occurrence
of the [Dha7]MC-LR variant occurring with high frequency
in NZ waters [3, 10, 11].
Microcystins are chemically stable over a wide range
of temperature and pH, possibly as a result of their cyclic
structure [12]. The toxins are also resistant to enzymatic
hydrolysis by some general proteases, such as pepsin, trypsin,
collagenase and chymotrypsin [13]. However, in the presence
of natural microbial populations, degradation of MCs can
take place. In 1994, Jones et al. successfully isolated from
Australian river water Sphingomonas strain MJ-PV (ACM-
3962), a single bacterial strain that utilized MC-LR as its
sole source of carbon, and nitrogen needed for growth [14].
Further research led to the elucidation ofMC-LRdegradation
2 ISRNMicrobiology
pathways of the bacterial strain ACM-3962 [15]. Two inter-
mediate degradation products were identified, suggesting
that at least three intracellular hydrolytic enzymes were
involved in the degradation of MC-LR. The first enzyme
identified in the degradation pathway, a metalloprotease
named microcystinase, cleaves the aromatic ring of MC-LR
at the Arg-Adda peptide bond. This step yields a linearized
MC-LR, which has a 160-fold reduction in toxic activity
compared with the parent MC-LR. Next, a serine peptidase
catalyzes the linearized MC-LR at the Ala-Leu peptide bond,
producing a tetrapeptide. Finally, the third enzyme, another
metalloprotease, cuts the peptide bonds randomly resulting
in undetectable peptide fragments and amino acids [16].
Bourne et al. [16] further performed cloning and molecular
characterization of four genes (mlrA,B, C, andD) that encode
the three hydrolytic enzymes plus a putative oligopeptide
transporter, all involved in the MC degradation metabolic
pathway of the Sphingomonas strain ACM-3962.
Cyanobacterial blooms and MC production in NZ water
bodies have been investigated by Wood [3] who detected
MCs in 102 water samples from 54 different locations. The
samples collected from Lake Rotoiti, Lake Hakanoa, Lake
Horowhenua, and Lake Waitawa in April 2003 contained
high levels of MCs, ranging from 0.02 𝜇gml−1 to a maxi-
mum of 36,500 𝜇gml−1. Wood [3] revealed the presence of
[Dha7]MC-LR, MC-LR, MC-RR, MC-AR, MC-FR, MC-LA,
MC-WR, MC-YR, and MC-LY from Lake Horowhenua, and
MC-LR, MC-RR, MC-AR, MC-FR, MC-LA, MC-WR, and
MC-YR from Lake Rotoiti [17]. Somdee [18] purified seven
MC variants from lyophilized bloom samples (20 g each) of
Microcystis aeruginosa collected from Lake Horowhenua in
May 2005, with [Dha7]MC-LR, the major variant (purity
of 93% and total yield of 51.84mg), along with moderate
amounts of MC-LR, MC-RR, MC-dMe-RR, MC-AR, MC-
FR, and MC-YR. Contamination of drinking water sources
by cyanotoxins [19] remains a serious threat to animal and
human health and thus degradation of MCs by naturally
occurring bacteria is an attractive bioremediation option
for removing MCs from drinking and recreational water
sources and supplies. The objectives of this research were
to (a) isolate and identify natural aquatic bacteria from
NZ water bodies capable of degrading MCs, (b) ascertain
optimal biodegradation conditions for the identifiedNZMC-
degrading bacteria, and (c) determine the biodegradation
pathway by the identified NZ MC-degrading bacteria for
[Dha7]MC-LR, the most common MC variant in NZ waters.
2. Materials and Methods
2.1. Isolation ofMC-Degrading Bacteria. Water samples taken
from Lake Rotoiti, Lake Rotorua, Lake Rotoehu, and Lake
Horowhenua, during blooms ofMicrocystis aeruginosa, were
used as potential sources of MC-degrading bacteria. 10mL
samples of lake water were inoculated into 190mL of a sterile
mineral salts medium (MSM) broth containing [Dha7]MC-
LR and MC-LR as the main food source for 5 days and incu-
bated in the dark at 30∘C in a shaking incubator (200 rpm).
Five subcultures were established per water sample. MC-
degrading bacteria were isolated by streaking serial dilu-
tions of 10−2 to 10−8 onto peptone-yeast extract medium
agar plates (PYEM) and incubated at 30∘C. Morphologically
distinct colonies on the plates were restreaked onto new
plates for purity. A single colony of each bacterial isolate
was grown on 5mL PYEM broth overnight at 30∘C in a
shaking incubator (200 rpm). 1mL of overnight culture was
inoculated into 19mL of fresh MSM broth containing MCs
at a final concentration of 25𝜇g mL−1 and incubated at
30∘C in a shaking incubator (200 rpm) for 7 days. The MC
degradation products were analysed individually for each
isolate. A 1mL sample was withdrawn at 1 day intervals,
centrifuged (12000 rpm for 10min), and the supernatant
analyzed on HPLC (UV detector). Bacterial isolate NV-3
was selected for further characterisation and examination of
biodegradative capacity.
2.2. 16𝑆 rRNA Sequencing of NV-3 Isolate. Sequencing of
16S rRNA was carried out by ESR, New Zealand, using an
ABI PRISM BigDye terminator DNA sequencing kit and
analyzed on a model 3730XL ABI DNA sequencer (Applied
Biosystems). The DNA sequences were compared with the
GenBank, EMBL, and DJB prokaryote databases using the
default settings of the Fasta3 alignment programme through
the EBI server.
2.3. Extraction of [Dha7]MC-LR and MC-LR for Biodegrada-
tion Experiments. A mix of [Dha7]MC-LR and MC-LR was
considered ideal as a substrate for the biodegradation exper-
iments (determination of optimal degradation conditions
and examination of biodegradative by-products), as extracts
rich in [Dha7]MC-LR have not previously been studied, and
New Zealand natural bloom sources were deemed more
appropriate than pure commercial forms of MC. Extraction
and purification of [Dha7]MC-LR and MC-LR MCs from
lyophilized bloom samples were performed as described by
Somdee [18]. The MC variants were identified by HPLC and
LC-MS/MS.
2.4. Investigation of Effect of Temperature, Bacterial, and MC
Concentration on Degradation of MCs by NV-3 Isolate. The
pure bacterial isolate NV-3 was cultured in a PYEM broth
for 36 h (late exponential growth phase determined from
bacterial growth curve experiment) in a shaking incubator
at 30∘C and 200 rpm. The bacterium was centrifuged at
12,000 rpm for 5min (4∘C). The supernatant was decanted,
and the pellet was resuspended in 0.05M phosphate buffer,
pH 7.0. This washing process was repeated three times. The
final pellet was resuspended in 5mL of sterile MSM broth,
and this bacterial culture was used for examining the effect
of temperature, bacterial, and MC concentrations on MC
degradation by the bacterium isolate NV-3.
2.5. Temperature Experiments. Sterile MSM broth was added
to the prepared bacterial culture to adjust the concentra-
tion of the stock culture to give an optical density of 1.0
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(OD
600
) and bacterial concentration of approximately 1.0 ×
10
8 CFU/mL. To establish the effect of temperature on MC
degradation, 9 mL of the NV-3 bacterial culture was mixed
with 1 mL of [Dha7]MC-LR and MC-LR (25 𝜇g/mL final
concentration). The experiment was carried out in triplicate
at 6 different temperatures, 10, 15, 20, 25, 30, and 35∘C,
in a shaking incubator at 200 rpm. The biodegradation of
MCs was monitored for each experiment over a period of
28 days. An aliquot (1mL) of the bacterial/cyanotoxin mix
was withdrawn after 0, 1, 3, 5, 7, 10, 14, 21, and 28 days of
incubation and centrifuged at 12,000 rpm for 10min. The
MC concentration was determined in the supernatant using
HPLC.
2.6. Bacterial Concentration Experiments. Using the opti-
mum temperature forMCdegradation, experiments to deter-
mine the effect of bacterial concentration onMCdegradation
were carried out at different bacterial concentrations with a
fixed MC concentration of 25𝜇g/mL. Five bacterial concen-
trations were prepared OD
600
= 0.1 (bacterial concentration
approximately 7.9 × 106 CFU/mL), OD
600
= 0.3 (2.5 × 107
CFU/mL), OD
600
= 0.5 (4.9×107 CFU/mL), OD
600
= 1.0 (1.0×
10
8CFU/mL), and OD
600
= 1.5 (1.45 × 108 CFU/mL), using
the prepared bacterial culture and adding sterile MSM broth
until the requiredODat 600 nmwas obtained. A 9mL sample
of each bacterial concentration was mixed with 1 mL of
[Dha7]MC-LR and MC-LR (25 𝜇g/mL final concentration).
The experiments were carried out in a shaking incubator at
the optimum temperature (30∘C) and at 200 rpm. Progressive
biodegradation of MCs was monitored over 3 days.
2.7. Substrate (Microcystin) Concentration Experiments. The
optimum temperature and bacterial concentration were used
to establish optimum MC concentration for bacterial degra-
dation. 9 mL of the bacterial culture (OD
600
= 1.0) was mixed
with 1 mL of [Dha7]MC-LR and MC-LR, yielding final MC
concentrations of 1, 10, 25, and 50𝜇g/mL, and incubated in
a shaking incubator at 30∘C and 200 rpm. The progressive
biodegradation of the MCs was monitored over 6 days.
2.8. Detection of MC-Degradation By-Products. The [Dha7]
MC-LR and MC-LR variants extracted and purified from
natural algal bloom were used in the biodegradation assays
for detection of MC-degradation by-products by the NV-3
isolate. The pure NV-3 isolate was transferred to 19 mL of
fresh MSM broth, containing MCs at a final concentration
of 25 𝜇g mL−1 and incubated in a shaking incubator at 30∘C
and 200 rpm. Samples (1 mL) were taken every 6 h until
48 h, and theMC-degradation by-productswere detected and
analyzed using LC/MS-MS at Cawthron Institute, Nelson,
New Zealand.
2.9. Detection of Genes Encoding MC-Degrading Enzymes.
The isolated bacterium (NV-3 isolate) was cultured in
peptone-yeast extract broth for 36 h at 30∘C and 200 rpm.
Genomic DNA was extracted using the Wizard Genomic
DNA Purification Kit (Promega) and quantified by a biopho-
tometer (Eppendorf) with A260/280 ratio. PCR primers for
amplification of mlrA gene are listed in Saito et al. [20] and
formlrB,mlrC, andmlrDgenes are described inHo et al. [21].
The PCR reactions were composed of 1 ng genomic DNA,
1 pmol of each primer, 1× PCR buffer (Invitrogen), 2mM
dNTPs (Invitrogen), 2.5mM MgCl
2
(Invitrogen), and 1.25
units of AmpliTaq Gold DNA polymerase (Applied Biosys-
tems), giving a final volume of 20 𝜇L. The amplification was
performed on a programmable thermal cycler (hybaid P×2
thermal cycler) with temperatures and times as previously
described by Saito et al. [20] for mlrA and Ho et al. [21]
for mlrB, C, and D. The PCR products were then purified
using theWizard SVgel andPCRclean-up system (Promega),
and both strands were directly sequenced on an ABI-3730
automated sequencer (Applied Biosystems), at Allan Wilson
Centre (AWC) Genome Sequencing Centre, Massey Univer-
sity, NZ. Assembled sequences were aligned using a ClustalW
with MEGA 4.0 program (retrieved December 10, 2008,
from http://www.megasoftware.net/) and then subjected to a
nucleotide BLAST search.
3. Results
Water samples obtained from Lake Rotoiti, Lake Rotoehu,
Lake Rotorua, and Lake Horowhenua were plated on MSM
broth with [Dha7]MC-LR and MC-LR as the sole carbon
and nitrogen source. A total of 27 isolates of different types,
shapes, and colors of colony were selected; however, only
three isolates that were obtained from Lake Rotoiti, desig-
nated NV-1, NV-2 and NV-3, were truly able to break, down
the MCs (data not shown). NV-3 isolate showed greatest
degradation activity and was used for characterization and
further experiments.
3.1. 16𝑆 rRNA Sequence of NV-3 Isolate. The 16S rRNA
sequence of the isolate NV-3 was determined and compared
with the GenBank, EMBL, and DJB prokaryote databases.
The databases revealed that the 16S rRNA sequences of the
NV-3 isolate resemble the sequences of Sphingomonas strain
MD-1 (AB110635), with 100% sequence homology for 1436
continuous nucleotides, and exhibits 98.5% homology with
16S rRNA of Sphingomonas stygia (AB025013). The NV-3
isolate was classified as a Sphingomonas sp., indistinguishable
from the Sphingomonas strain MD1.
3.2. Effect of Temperature, Bacterial, and MC Concentration
on Biodegradation. The effect of temperature on the ability
of NV-3 (1.0 × 108 CFU/mL) to degrade 25 𝜇g/mL MCs was
investigated. MC degradation by NV-3 began on day 1 under
all temperatures tested (Figure 1(a)); however, the rate of MC
degradation varied with temperature. The degradation rate
was slowest at 10∘C (0.89𝜇g/mL/day) and steadily increased
with increasing temperatures to 35∘C (8.30 𝜇g/mL/day). MC
concentrations rapidly decreased at temperatures from 20∘
to 35∘C, with complete degradation occurring within 5
days (Figure 1(a)). However, at these temperatures a notice-
able drop off in degradation rate occurred after the initial
rapid phase. The highest degradation rate was reached with
temperatures of 30∘C (8.33 𝜇g/mL/day); however, the rate
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Figure 1: (a) Biodegradation of [Dha7]MC-LR and MC-LR with bacterial isolate NV-3 at temperatures of 10∘, 15∘, 20∘, 25∘, 30∘, and 35∘C;
(b) varying rates of [Dha7]MC-LR and MC-LR biodegradations with varying bacterial concentrations. (c) [Dha7]MC-LR and MC-LR
biodegradations at varying MC concentrations (1, 10, 25, and 50𝜇g/mL).
of degradation during the initial rapid phase was similar
between temperatures of 25, 30, and 35∘C and was calcu-
lated to be approximately 8.30 𝜇g/mL/day.These experiments
demonstrated that the optimum temperature for NV-3 isolate
biodegradation of [Dha7]MC-LR and MC-LR variants was
30∘C.
The optimum bacterial concentration of NV-3 isolate for
degradation of 25𝜇g/mL MCs was then investigated at 30∘C
(being the optimum temperature forMC degradation byNV-
3). Bacterial concentrations of 7.9 × 106, 2.5 × 107, 1.0 ×
10
8, and 1.45 × 108 CFU/mL completely degraded the MCs
within 3 days (Figure 1(b)). However, the degradation rate
was slow with the lowest bacterial concentrations 7.9 × 106
and 2.5 × 107 CFU/mL. After one day of incubation with
7.9 × 10
6 and 2.5 × 107 CFU/mL NV-3 isolate, the amount
of [Dha7]MC-LR remaining was 80% and 40%, respectively.
By contrast, after incubation with the higher NV-3 isolate
concentrations of 4.9×107, 1.0×108, and 1.45×108 CFU/mL,
less than 20% of [Dha7]MC-LR remained. The MC degra-
dation rate in general increased with increasing bacterial
concentration. At bacterial concentrations of 4.9 × 107,
1.0 × 10
8 and 1.45 × 108 CFU/mL, the degradation rates were
not significantly different with the same degradation rate
of 8.33 𝜇g/mL/day. However, the degradation rate actually
decreased slightly at the highest bacterial concentration of
1.45×10
8 CFU/mL.These experiments demonstrated that the
optimum bacterial concentration for NV-3 isolate biodegra-
dation of [Dha7]MC-LR and MC-LR variants was 1.0 ×
10
8 CFU/mL. The effect of variation in MC concentration
on NV-3 isolate degradation capability was also investigated
at 30∘C and NV-3 concentration 1.0 × 108 CFU/mL. At
low MC concentrations (1 and10 𝜇g/mL), the toxins were
completely degraded in one day, whereas at higher concen-
trations of toxins (25 and 50𝜇g/mL) degradation took longer,
reaching undetectable levels by day 3 and 6 respectively
(Figure 1(c)).The rate of degradation for concentrations of 25
and 50 𝜇g/mL was equal at 8.33 𝜇g/mL/day.
3.3. Detection of MC-Degrading By-Products. Biodegrada-
tion of MCs was induced using a mixture of [Dha7]MC-
LR and MC-LR (25 𝜇g/mL final concentration) with cell
suspensions of the isolate NV-3 (1.0 × 108 CFU/mL). The
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Figure 2: Visualisation ofMS/MS spectrum data of degradation by-products of [Dha7]MC-LR andMC-LR in ESI+ with parent ion spectrum
for MS-MS channels set up. (a) [Dha7]MC-LR at m/z 981.75, (b) MC-LR at m/z 995.75, (c) [Dha7]MC-LR degradation by-product A at m/z
999.4 and MC-LR degradation by product A atm/z 1013.5, (d) [Dha7]MC-LR degradation by-product B atm/z 601.2.
toxin concentration began to decline, and two peaks,
referred to as by-products A and B, were detected in a
HPLC chromatogram. The peaks corresponding to the by-
products increased gradually, while the peak correspond-
ing to the parent toxins decreased. The by-products from
microbial catabolism were further analyzed using LC/MS-
MS. [Dha7]MC-LR is 14 mass units less than MC-LR due
to the loss of a methyl group at Mdha, and the m/z at
981.75 and 995.75 confirmed that [Dha7]MC-LR, and MC-
LR, respectively, were present in the biodegradation assay
samples (Figures 2(a) and 2(b)). By-product A revealed the
base peak at m/z 999 (Figure 2(c)) and was analogous to
the linearized peptide of [Dha7]MC-LR (NH
2
-Adda-D-Glu-
Dha-D-Ala-L-Leu-D-MeAsp-L-Arg-OH). The ion spectra of
the prominent ion atm/z 848.4 (Figure 2(c)), which was from
the loss of PhCH
2
CHOMe from the linearized peptide of
[Dha7]MC-LR, confirmed the ring opening of [Dha7]MC-
LR. The biodegradation by-product B revealed the base peak
at m/z 601.2 (Figure 2(d)). The [M+H]+ ion 601.2 is the
tetrapeptide of [Dha7]MC-LR (NH
2
-Adda-D-Glu-Dha-D-
Ala-OH), 14 mass units less than the tetrapeptide of MC-LR
microbial degradation reported in Bourne et al. [15].
3.4. Detection of MC-Degrading Genes. DNA fragments of
the NV-3 isolate mlrA (720 bp), B (340 bp), C (590 bp), and
D (600 bp) genes were PCR amplified and then directly
sequenced. The DNA sequences were investigated using
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BLASTN search. The mlrA nucleotides (721 bp) exhibited a
99%DNA sequence similarity to the 807 base pair nucleotide
sequence of the mlrA gene from Sphingomonas strain MD-
1 (NCBI accession number AB114202). The mlrB337 bp
revealed a 94% similarity to the 448 nucleotide base pair
sequence of the mlrB gene from Sphingopyxis sp. LH21
(DQ423530), whereas the nucleotide sequence of mlrC
(588 bp) and mlrD (597 bp) genes was 99% and 97% similar
to the respective genes (with 666 bp and 671 bp) from Sphin-
gomonas sp. ACM-3962 (AF411070 and AF411071).
4. Discussion
The presence of microcystins (MCs) in freshwater is becom-
ing an increasing problem and poses a potential threat to
human health around the world. The MC toxin is well
recognized as a stable and persistent compound; however,
reports have shown that MCs are vulnerable to break down
by indigenous bacteria established in natural water [2, 14,
22–25]. This is the first study to isolate and characterize
indigenous MC-degrading bacteria in New Zealand waters.
We have demonstrated that the bacterium isolate NV-3 from
Lake Rotoiti is able to utilise [Dha7]MC-LR and MC-LR
as a sole source of carbon and energy. On the basis of 16S
rRNA sequences the isolate NV-3 is indistinguishable from
the Sphingomonas strain MD-1 from Japan.
The rate of MC degradation by any bacterial isolate,
including NV-3, relies mainly on the incubation temperature
as well as bacterial concentration. Biodegradation of MCs by
the bacterium occurred under a wide range of temperatures
between 10∘C and 35∘C. At 10∘C, the biodegradation was very
slow and identical to that of the MC degrading-bacterium
Sphingopyxis strain LH21, isolated from Australia, suggesting
that it would similarly not be able to degradeMCs at 4∘C [21].
The ability of bacteria to degrade toxins in low temperatures
is relevant to the degradation of toxins in winter, for example,
when the water temperature is low. For NV-3, increases in
water temperature from 15∘C to 30∘C were associated with
an increase in biodegradation rate; however, temperatures
higher than the optimum temperature (30∘C) for NV-3
bacterial growth resulted in slightly decreased degradative
ability. It is likely that at high temperatures, NV-3 bacterial
cells are unable to produce MC-degrading enzymes, or the
cells might be inactive or growing slowly. The highest rate of
MC-degradation by the isolate NV-3 was achieved at 30∘C, a
similar temperature observed formaximumMC-degradation
by the Sphingomonas strain Y2, isolated from Lake Suwa,
Japan [26], and for Sphingopyxis strain TT25 isolated from
Australian waters, the highest rate was achieved at 25∘C [27].
At the optimum temperature of bacterial growth, the bacterial
metabolism is very active, producing a lot of enzymes
responsible for MC degradation. By contrast, at temperatures
that are lower or higher than that for optimum growth,
bacterial metabolism and the production of biodegradation
enzymes are presumably less active, slowing the rate of MC
degradation.
Biodegradation of toxins is also dependent on bacterial
concentration. In this study, the degradation rate increased
with increasing bacterial cell concentration; however, con-
centrations above 1.0 × 108 CFU/mL resulted in a decrease in
degradative ability.This decreasemight be due to competition
or inhibition between the cells at very high cell numbers,
and, therefore, the optimum cell density is also crucial for
toxin degradation. In this study, the optimum cell density
of the bacterium isolate NV-3, required for MC degradation
experiments, was between 4.9 × 107 to 1.0 × 108 CFU/mL and
theminimumnumber of cells required was approximately 7.9
× 106 CFU/mL. It is interesting that at the minimum cell den-
sity, MCs were completely degraded within 3 days, the same
length of time taken with higher concentrations of bacteria.
This confirms the ability of the bacterium isolate NV-3 to
utilise the toxins as their own food and to multiply itself to
a cell density sufficient to completely degrade the MCs. The
effect of toxin concentrations on MC degradation by NV-3
was also examined. In this study, at the optimum temperature
(30∘C) and bacterial concentration (1.0 × 108 CFU/mL), the
biodegradation rate increased with increasing concentrations
of the toxins (the mixture of [Dha7]MC-LR, and MC-LR).
The degradation rate by the bacterial isolate was identical
(i.e., 8.33 𝜇g/mL/day) for moderate to high concentrations
of the toxins (25 𝜇g/mL to 50𝜇g/mL). It is possible that as
the sole carbon and nitrogen sources for bacterial growth,
high concentrations of MCs were beneficial to growth of the
isolated bacteria. However, the apparent inhibitory effects of
very high toxin concentrations (i.e.,>50𝜇g/mL) and the limit
to the amount of MCs that NV-3 can degrade need to be
further investigated, as the effects on bacterial growth and
metabolism are unknown.
Biodegradation studies ofMCs have beenmainly focused
on the MC-LR variant since it is found worldwide and
possesses high toxicity (LD
50
(ip) = 50 𝜇g/kg in mice) [1, 8,
9, 28]. Other analogues of MCs such as MC-RR, YR, LW, and
LF have also been examined [13, 26, 29–35]. In New Zealand
waters it appears that [Dha7]MC-LR is in greater quantity
than MC-LR [3, 10, 11]. In this study, in addition to MC-
LR, [Dha7]MC-LR was used as a substrate to characterize
the biodegradation pathway of [Dha7]MC-LR using the bac-
teriumisolate NV-3. Previous studies have shown that at least
three hydrolytic enzymes are involved in degradation of MC-
LR [15, 16]. Our study has shown that the by-products A and
B of [Dha7]MC-LR (Figures 2(c) and 2(d)) are degradation
products equivalent to what happens to MC-LR (Figure 3) in
an enzymatic pathway identical to that described by Bourne
et al. [15]. It is important to note that the MC-degradation
by-products, namely linearized peptides, tetrapeptides and
peptide fragments are significantly less toxic than the parent
molecules of MCs. Bourne et al. [15] demonstrated that the
toxicity of the linearized peptides of MC-LR is reduced 160-
fold comparedwith the parent compound,while other studies
have demonstrated that tetrapeptide and amino acids are
nontoxic [36].These findings strongly indicate that microbial
degradation is a potentially safe and natural treatment for
removing MCs from water [37].
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[Dha7]MC-LR (MW 981.75) MC-LR (MW 995.75) MC variant
Enzyme encoded by mlrA gene
Linearised peptide (MW 999) Linearised peptide (MW1013) By-product A
Enzyme encoded by mlrB gene
Tetrapeptide (MW 601.2) Tetrapeptide (MW 615.2) By-product B
Enzyme encoded by mlrC gene
Smaller peptides and amino acids Smaller peptides and amino acids
Figure 3: Putative pathway for [Dha7]MC-LR degradation by Sphingomonas isolate NV-3 based on published data regarding MC-LR
degradation pathway [15, 16]. Refer to Figure 2 for visualisation of degradation by-products. MW: molecular weight.
5. Conclusion
In summary, (1) bacteria were found in New Zealand lakes
with the ability to degrade [Dha7]MC-LR and MC-LR as
the sole carbon and nitrogen sources; (2) 16S RNA of
the MC-degrading bacteria isolated were indistinguishable
from a previously identified bacterium MD-1 which was
located in Japan; (3) optimal NV-3 degradation of 25 𝜇g/mL
[Dha7]MC-LR and MC-LR prepared form a natural algal
bloom, occurred at 30∘C with bacterial concentration of
1.0 × 108 CFU/mL, and(4) the by-products A and B from
biodegradation of [Dha7]MC-LR and the detection of mlrA,
mlrB, mlrC, and mlrD genes in NV-3 genome indicate that
degradation of [Dha7]MC-LR is via a similar mechanism for
degradation of MC-LR as described by Bourne et al. [15,
16].This study has demonstrated that microcystin-degrading
bacteria are present in New Zealand water bodies, and that
these bacteria could be used potentially on a larger scale for
removing microcystins from water.
5.1. Nucleotide Sequence Accession Numbers. The four gene
sequences mlrA, mlrB, mlrC, and mlrD obtained for Sph-
ingomonas NV-3 isolate have been deposited in GenBank
under accession numbers JN256930, JN256929, JN256928,
and JN256927, respectively.
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